JPH0446117A - Preparation of plaster with adhesive sheet - Google Patents
Preparation of plaster with adhesive sheetInfo
- Publication number
- JPH0446117A JPH0446117A JP15390390A JP15390390A JPH0446117A JP H0446117 A JPH0446117 A JP H0446117A JP 15390390 A JP15390390 A JP 15390390A JP 15390390 A JP15390390 A JP 15390390A JP H0446117 A JPH0446117 A JP H0446117A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- adhesive sheet
- release liner
- adhesive
- patch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000853 adhesive Substances 0.000 title claims abstract description 87
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 84
- 239000011505 plaster Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 claims abstract description 53
- 239000003814 drug Substances 0.000 claims abstract description 53
- 238000005520 cutting process Methods 0.000 claims abstract description 23
- 238000004080 punching Methods 0.000 claims abstract description 19
- 238000003892 spreading Methods 0.000 claims abstract description 6
- 238000010030 laminating Methods 0.000 claims abstract 3
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000002390 adhesive tape Substances 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 7
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 239000002985 plastic film Substances 0.000 description 3
- 229920006255 plastic film Polymers 0.000 description 3
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 239000005061 synthetic rubber Substances 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- -1 carphobol Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野〕
本発明は患部の皮膚に貼着して使用される貼付剤に関す
るものであり、特に粘着シートの形状や粘着シート上に
載置される薬剤の形状を任意に選択できる粘着シート付
き貼付剤の製造方法に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a patch that is used by being attached to the skin of an affected area, and in particular, the shape of the adhesive sheet and the drug placed on the adhesive sheet. The present invention relates to a method for manufacturing a patch with an adhesive sheet, in which the shape of the adhesive sheet can be arbitrarily selected.
[従来の技術]
患部の皮膚に貼着して使用される貼付剤は、貼着の際に
貼付剤のズレ・脱落を防止するために、粘着シートを貼
付剤の上から更に貼着して使用していた。[Prior art] For patches that are applied to the skin of an affected area, an adhesive sheet is further applied over the patch to prevent the patch from slipping or falling off during application. I was using it.
このため、貼付剤の大きさ・形状に見合った粘着シート
を個別に販売したり、貼付剤に付録として付して販売し
ている製品もある。For this reason, some products sell adhesive sheets that match the size and shape of the patch individually, or are sold as an appendix to the patch.
しかしながら、貼付剤を貼着した後に、更に粘着シート
を貼着することは面倒であり、貼付剤に対して粘着シー
トがズして貼着されたりする失敗も多かフた。このため
、製品時に既に粘着シートの中央に貼付剤を保持した粘
着シート付き貼付剤が切望されていた。製品時に既に粘
着シートの中央に貼付剤を保持した粘着シート付き貼付
剤は、切望されていたが、粘着シート付き貼付剤を得る
前記何れの製造方法も、貼付剤の薬剤がゲル状であるた
め、取扱いが困難であり、剥離ライナーを貼り合せるま
でにゴミ等の混入や有効成分の蒸散等の問題があった。However, it is troublesome to further apply an adhesive sheet after applying the adhesive patch, and there are many failures such as the adhesive sheet slipping off the adhesive. For this reason, there has been a strong desire for a patch with an adhesive sheet that already holds the patch in the center of the adhesive sheet when it is manufactured. A patch with an adhesive sheet that already holds the patch in the center of the adhesive sheet at the time of production has been highly desired, but none of the above-mentioned manufacturing methods for producing a patch with an adhesive sheet are difficult because the drug in the patch is in a gel form. However, it is difficult to handle, and there are problems such as contamination with dust and evaporation of the active ingredient before the release liner is attached.
また、粘着シートの粘着面上への正確な貼りつけの困難
があり、連続的な生産工程の確立や、ゲル状の薬剤を正
確に成形・載置する機械・ゲル状の薬剤を露出させたま
ま載置する機械等の新たな機械の作成が必要であった。In addition, it is difficult to accurately attach the adhesive sheet to the adhesive surface, and it is necessary to establish a continuous production process and to create a machine that accurately molds and places the gel-like drug. It was necessary to create a new machine, such as a machine that would allow it to be placed in the same position.
このため、本願発明者らは、特願平1−220244号
で粘着テープを貼着する煩雑さを解消した粘着テープ付
きパップ剤を提供し、更に該パップ剤を不良品が少なく
、連続的に製造する製造方ン去を提イ共した。For this reason, the inventors of the present application have provided a poultice with an adhesive tape that eliminates the trouble of attaching an adhesive tape in Japanese Patent Application No. 1-220244, and furthermore, the present inventors have provided a poultice with an adhesive tape that eliminates the trouble of attaching an adhesive tape, and furthermore, the poultice can be continuously manufactured with fewer defective products. We shared the manufacturing method.
[発明が解決しようとする課題]
本発明は前述の発明を更に改良して、特に粘着シートの
形状や粘着シート上に載置される薬剤の形状を任意に選
択でき、然も原材料、特に薬剤及び支持体のロスが少な
い粘着シート付き貼付剤の製造方法を得ることを目的と
する。[Problems to be Solved by the Invention] The present invention further improves the above-mentioned invention, and allows the shape of the pressure-sensitive adhesive sheet and the shape of the drug placed on the pressure-sensitive adhesive sheet to be arbitrarily selected. Another object of the present invention is to obtain a method for producing a patch with an adhesive sheet that causes less loss of the support.
[課題を解決するための手段]
本発明に係る粘着シート付き貼付剤の製造方法では、薬
剤を支持体面上に展延塗布し、該薬剤面側に第1の剥離
ライナーを貼り合せる工程と前記第1の剥離ライナーを
残して前記支持体と薬剤との積層体を隣接抜き形状に切
断する工程と ;
前記隣接した積層体を前記第1の剥離ライナーから剥離
し、前記隣接した積層体間に所定間隔を設けて第2の剥
離ライナーに貼り替える工程と。[Means for Solving the Problems] The method for producing a patch with an adhesive sheet according to the present invention includes the steps of spreading and coating a drug onto a support surface, and bonding a first release liner to the drug surface side; cutting the support-drug laminate into adjacent punched shapes leaving a first release liner; peeling the adjacent laminates from the first release liner; and a step of replacing it with a second release liner at a predetermined interval.
前記積層体を覆うように前記第2の剥離ライナー表面に
粘着シートを貼り合せる工程前記積層体を覆う粘着シー
トを所定の別の抜き形状に打ち抜き、該抜き形状以外の
余分な粘着シートを前記第2の剥離ライナー上から除去
する工程;
前記第2の剥離ライナーを小分は裁断する工程;とを有
するものである。A process of bonding an adhesive sheet to the surface of the second release liner so as to cover the laminate. The adhesive sheet covering the laminate is punched out into another predetermined shape, and the excess adhesive sheet other than the shape is removed from the second release liner. The second release liner is removed from the second release liner; and the second release liner is cut into small pieces.
[作用]
本発明においては、薬剤を支持体面上に展延塗布し、該
薬剤面側に第1の剥離ライナーを貼り合せる工程と、前
記第1の剥離ライナーを残して前記支持体と薬剤との積
層体を隣接抜き形状に切断する工程と:前記隣接した積
層体を前記第1の剥離ライナーから剥離し、前記隣接し
た積層体間に所定間隔を設けて第2の剥離ライナーに貼
り替える工程と、前記積層体を覆うように前記第2の剥
離ライナー表面に粘着シートを貼り合せる工程:前記積
層体を覆う粘着シートを所定の別の抜き形状に打ち抜き
、該抜き形状以外の余分な粘着シートを前記第2の剥離
ライナー上から除去する工程、前記第2の剥離ライナー
を小分は裁断する工程;とを有するものであるため、第
1抜き形状に打ち抜く際に粘着周縁部に要する部分を見
込んでおく必要かないので、粘着周縁部に要していたは
ずの薬剤、原材料のロスが生じない。[Function] The present invention includes the steps of spreading and coating a drug onto the support surface, bonding a first release liner to the drug surface side, and bonding the drug to the support while leaving the first release liner. cutting the laminate into adjacent punched shapes; and: peeling off the adjacent laminate from the first release liner and replacing it with a second release liner with a predetermined interval between the adjacent laminates. and a step of bonding an adhesive sheet to the surface of the second release liner so as to cover the laminate: punching out the adhesive sheet covering the laminate into another predetermined punched shape, and removing any excess adhesive sheet other than the punched shape. and cutting the second release liner into small pieces; therefore, when punching out the first punched shape, the area required for the adhesive peripheral portion is removed. Since there is no need to make allowances, there is no loss of chemicals or raw materials that would have been required for the adhesive periphery.
また第1、第2の剥離ライナーは、それぞれロール状に
つながった状態で用いるので、位置決めし易く、各製造
段階は一連の機械的な流れによるものであるため、工程
中の素材ロスによる費用に比較して、不良品の低減等に
より製造効率か非常に優れている。Additionally, since the first and second release liners are used in a connected roll, they are easy to position, and each manufacturing step is a series of mechanical flows, reducing costs due to material loss during the process. In comparison, manufacturing efficiency is very high due to reduction in defective products.
[実施例]
第1図は本発明で得られた粘着シート付き貼付剤の構成
を示す上面図であり、第2図は第1図の断面図である。[Example] FIG. 1 is a top view showing the structure of a patch with an adhesive sheet obtained according to the present invention, and FIG. 2 is a sectional view of FIG. 1.
図において、角丸矩形状の支持体21の全面に薬剤22
を展延塗布して積層形成された貼付剤23かある。この
貼付剤23の外形外周に沿って角丸矩形状の粘着シート
24が被着されている。これら貼付剤23の薬剤22と
粘着シート24の前記粘着周縁の粘着面34とを被覆し
た矩形状の剥離ライナー26とを備えた粘着シート付き
貼付剤である。In the figure, a drug 22 is applied to the entire surface of a support 21 having a rounded rectangular shape.
There is a patch 23 which is formed by spreading and applying a laminated layer. A rectangular pressure-sensitive adhesive sheet 24 with rounded corners is attached along the outer periphery of the adhesive patch 23 . This adhesive patch includes a rectangular release liner 26 that covers the drug 22 of the adhesive patch 23 and the adhesive surface 34 of the adhesive periphery of the adhesive sheet 24.
貼付剤23の外形は、本実施例では角丸矩形状としたが
、その他にも例えば矩形型、楕円形型、克復、菱型、ヒ
ョウタン型等自由に選べることができ、粘着シート24
の形状も本実施例のように貼付剤23の外形外周に沿っ
て均等な周縁の幅であっても良く、また更に少なくとも
種々の形状の貼付剤23を広く覆う大きさであればどの
ような形状のものでも良い。更に剥離ライナー26も少
なくとも貼付剤23の薬剤22と粘着シート24の前記
粘着周縁の粘着面34とを被覆するものであるならば、
どのような形状をも取り得る。Although the external shape of the adhesive patch 23 is a rectangular shape with rounded corners in this embodiment, it can be freely selected from other shapes such as a rectangular shape, an oval shape, a square shape, a diamond shape, a gourd shape, etc.
The shape of the patch 23 may have a uniform width along the outer circumference of the adhesive patch 23 as in this embodiment, or may be of any size as long as it can at least cover a wide range of adhesive patches 23 of various shapes. It may be of any shape. Furthermore, if the release liner 26 also covers at least the drug 22 of the patch 23 and the adhesive surface 34 of the adhesive periphery of the adhesive sheet 24,
It can take any shape.
好ましくは、貼付剤23の外周に沿って張り出すように
設けられた粘着シートの粘着周縁の幅は5mm以上、更
に好ましくは5〜10mmが良い。即ち、5mm以下で
あると患部の伸縮に伴なう接着力の低下に対向で籾なく
なるためであり、110ff以上であれば接着力の低下
はないが、粘着シートの面積を広くとる必要があり、コ
ストアップとなるためである。Preferably, the width of the adhesive periphery of the adhesive sheet extending along the outer periphery of the patch 23 is 5 mm or more, more preferably 5 to 10 mm. That is, if it is less than 5 mm, the adhesive force will decrease due to the expansion and contraction of the affected area, and the rice will not be able to be removed. If it is more than 110 ff, there will be no decrease in adhesive force, but the area of the adhesive sheet will need to be widened. This is because the cost increases.
尚、本発明による粘着シート付き貼付剤の薬剤22は、
皮膚に直接効果のある薬剤及び経皮吸収により局部又は
全身に効果のある薬剤等を保形剤・粘着剤等の基剤に含
有したもので、ある。In addition, the drug 22 of the adhesive sheet-attached patch according to the present invention is as follows:
It contains drugs that have a direct effect on the skin and drugs that have a local or systemic effect through transdermal absorption in a base such as a shape-preserving agent or adhesive.
この薬剤22に含有される有効薬剤の具体的な例として
は、鎮痛消炎剤として、インドメタシン。A specific example of the effective drug contained in this drug 22 is indomethacin as an analgesic and anti-inflammatory agent.
ケトプロフェン、フルルビプロフェン、イブプロフェン
、ピロキシカム、サリチル酸メチル、サリチル酸グリコ
ール、l−メントール、d互−カンフル、ノニル酸ワリ
ニリルアシト、カブナイシン及び各種生薬がある。また
、冠血管拡張剤として、ニトログリセリン、ニフェジピ
ン、イソソルバイトナイトレート等がある。その他の薬
剤として、クロニジン、カリクレイン(抗高血圧剤)。These include ketoprofen, flurbiprofen, ibuprofen, piroxicam, methyl salicylate, glycol salicylate, l-menthol, d-camphor, varynylylaceto nonylate, kabnisin, and various herbal medicines. Coronary vasodilators include nitroglycerin, nifedipine, isosorbite nitrate, and the like. Other drugs include clonidine and kallikrein (antihypertensive drugs).
コルチコステロイド類、抗菌剤等かある。There are corticosteroids, antibacterial agents, etc.
また、必要に応じて薬剤22に含有される保形・粘着剤
の例としては、カルホキジメチルセルロスナトリウム、
メチルセルロースナトリウム、ポリビニルアルコール、
アルギン酸ナトリウム、ポリアクリル酸ナトリウム、ポ
リビニルピロリドン、ゼラチン、カーホボール等の増粘
剤、天然ゴム系1合成ゴム系、スチレン−イソプレン−
スチレンブロックコポリマー系、シリコーン樹脂系ポリ
ビニルエーテル系の粘着剤がある。In addition, examples of shape-retaining/adhesive agents that may be included in the drug 22 as needed include carboxydimethyl cellulose sodium,
Sodium methylcellulose, polyvinyl alcohol,
Thickeners such as sodium alginate, sodium polyacrylate, polyvinylpyrrolidone, gelatin, carphobol, natural rubber type 1 synthetic rubber type, styrene-isoprene-
There are adhesives based on styrene block copolymers, silicone resins, and polyvinyl ethers.
更に、必要に応して使用する保湿剤として、グーリセリ
ン、プロピレングリコール、ソルビトール等がある。Furthermore, as a humectant to be used as necessary, there are glycerin, propylene glycol, sorbitol, and the like.
また、本発明による粘着シート付き貼付剤の支持体21
は、薬剤の塗布・保持の役目をするものであり、薬剤の
性質により、最適なるものを選択する。即ち、薬剤と密
着すること、薬剤の裏もれを防止し、肌へのフィツト感
を高める伸縮性・通気性・風合の良いものが使用される
。Moreover, the support body 21 of the adhesive sheet-attached patch according to the present invention
serves to apply and retain the drug, and the most suitable one is selected depending on the properties of the drug. That is, the material used is one that has good elasticity, breathability, and texture so that it adheres closely to the drug, prevents the drug from leaking, and improves the fit to the skin.
その具体的な例としては、例えばネル、織布メリヤス1
不織布、アルミニウムフィルム、プラスチックフィルム
の単体もしくは複合材等を選択できる。尚、本発明によ
る製造方法の工程では打ち抜き工程があるのて、角丸、
スリット等と自由に形を作ることができる。Specific examples include flannel, woven stockinette 1
Single or composite materials such as non-woven fabric, aluminum film, and plastic film can be selected. In addition, since the manufacturing method according to the present invention includes a punching process, rounded corners,
You can freely create shapes with slits, etc.
更に、剥離ライナー26も、例えはグラシン紙、PET
、PP、PE、アルミフィルム等にシリコン加工したも
の、もしくはそのままのもの等、薬剤の付着性、成分の
移行性等の品質保持面より選択することがてきる。Furthermore, the release liner 26 is also made of glassine paper, PET, etc.
, PP, PE, aluminum film, etc. processed with silicon, or as is, can be selected based on quality maintenance aspects such as drug adhesion and component migration.
また、本発明による粘着シート付き貼付剤の粘着シート
24の支持体は、不織布(メツシュ及び伸縮性のものも
含む)織布、アルミニウムフィルム、プラスチックフィ
ルムの単体もしくは複合材に、生ゴム、合成高分子、樹
脂等の粘着材を備えたものが選択できる。この粘着シー
ト24は、薬剤と支持体を肌によりフィツトさせるため
に全周に設けたものであり、薬剤22が肌に密着して剥
がれないものであり、薬剤が周囲からはみ出ないように
して、患部に合わせた形状が種々に選択できる。The support of the adhesive sheet 24 of the adhesive patch according to the present invention is made of a single or composite material of non-woven fabric (including mesh and stretchable fabric), aluminum film, plastic film, raw rubber, synthetic polymer, etc. , one with an adhesive material such as resin can be selected. This adhesive sheet 24 is provided around the entire circumference in order to make the drug and support body fit better into the skin, and the drug 22 adheres closely to the skin and does not come off, and prevents the drug from protruding from the surrounding area. Various shapes can be selected depending on the affected area.
以上のように、下着等に薬剤22がついたり、容易に剥
がれたりする等か全くない粘着シート付き貼付剤が得ら
れる。具体的な粘着シート24の材質として、不織布、
プラスチックフィルム等の通気性の高い物が使用され、
細かい通気孔や中央部に大きな通気孔を有した構造をも
取り得るものである。As described above, a patch with an adhesive sheet can be obtained that does not cause the drug 22 to stick to underwear or the like and does not easily peel off. Specific materials for the adhesive sheet 24 include nonwoven fabric,
Highly breathable materials such as plastic films are used,
It is also possible to have a structure with small ventilation holes or a large ventilation hole in the center.
また、粘着シート24の粘着剤として、具体的な例とし
てはポリアクリル酸エステル系、天然・合成ゴム系、ス
チレン−イソプレン−スチレンブロックポリマー系のも
のであり、肌へのカブレの少ないものが使用される。Specific examples of the adhesive used in the adhesive sheet 24 include polyacrylic acid ester, natural/synthetic rubber, and styrene-isoprene-styrene block polymers, which cause less irritation to the skin. be done.
第3axd図は粘着シート付き貼付剤の製造工程の一実
施例を示す工程図である。FIG. 3AXD is a process diagram showing an example of the manufacturing process of a patch with an adhesive sheet.
第3a図に示す通り、薬剤22を帯状の支持体21に展
延塗布し、薬剤22層面上に第1の剥離ライナ25を積
層して帯状貼付剤33とする。以上のように、薬剤22
を支持体21に展延塗布してすぐに薬剤22層面上に第
1剥離ライナー25を貼り合せたので、ゴミ等の混入や
有効成分の蒸散か少ない。As shown in FIG. 3a, a drug 22 is spread and coated on a strip-shaped support 21, and a first release liner 25 is laminated on the surface of the drug 22 layer to form a strip-shaped patch 33. As mentioned above, drug 22
Since the first release liner 25 is bonded to the surface of the drug 22 layer immediately after it is spread and coated on the support 21, there is little chance of contamination with dust or the like and evaporation of the active ingredient.
第3b図に示す通り、帯状貼付剤33を表裏を逆にして
、下から順に第1剥離ライナー25.@剤22、支持体
21とする。この帯状貼付剤33を上方から角丸矩形状
の抜き型を有するロール式打ち抜き機29により支持体
21と薬剤22に切断線を入れ、貼付剤23とその外周
の余分な部分30を分動てきるようにする。更に、貼付
剤23の周りの余分な部分30を第1剥離ライナー25
上から除去する。得られた貼付剤23は帯状の第1剥鵬
ライナー25上に連続した状態で載置される。As shown in FIG. 3b, the strip-shaped patch 33 is turned upside down, and the first release liner 25. @Agent 22 and support 21. Cutting lines are cut into the support 21 and the drug 22 from above using a roll-type punching machine 29 having a rounded rectangular cutting die, and the patch 23 and the excess portion 30 on its outer periphery are cut out. so that Furthermore, the excess portion 30 around the patch 23 is removed by the first release liner 25.
Remove from above. The obtained adhesive patch 23 is placed continuously on the strip-shaped first peeling liner 25.
この時、ロール式打ち抜き機29の打ち抜き型は、本実
施例の角丸矩形状以外に、例えば矩形型、楕円形型、克
復、菱型等自由に選択できるが、余分な部分か出ない矩
形型での効率が良い。At this time, the punching die of the roll-type punching machine 29 can be freely selected from the rectangular shape with rounded corners in this embodiment, such as rectangular, elliptical, rectangular, diamond-shaped, etc.; Good efficiency in molds.
また、ロール式打ち抜き機29以外にも、正版打ち抜き
機等の打ち抜き機が使用できる。Further, in addition to the roll type punching machine 29, a punching machine such as a regular plate punching machine can be used.
次に第3C図に示すように貼付剤の戴置された剥離ライ
ナー25aの進行方向を変えて、剥離ライナー25a上
に連続した状態で載置された貼付剤23を剥がしとる。Next, as shown in FIG. 3C, the traveling direction of the release liner 25a on which the patch is placed is changed, and the patch 23 continuously placed on the release liner 25a is peeled off.
このとき、貼付剤23を剥かした後の剥離ライナー25
bと、貼付剤23か戴置された剥離ライナー25aのな
す角度αは90°よりlJ>さくする。l!J離ラピラ
イナー25b端をドラム等に巻き取るか、前工程に戻す
ようにすれは、第1の剥離ライナーは何度も使用するこ
とかできるので、剥離ライナーを2段階に分けて使用す
ることによって不利益が生しることはない。At this time, the release liner 25 after peeling off the patch 23
The angle α formed by b and the release liner 25a on which the patch 23 is placed is lJ> smaller than 90°. l! The first release liner can be used many times, so the first release liner can be used many times, so it is best to use the release liner in two stages. There will be no disadvantage.
剥離ライナー25aからはがされた貼付剤23は、i3
c図のように第2の剥離ライナー26に貼りつける。こ
のとき隣合う貼付剤23の間に受なくとも粘着周縁部と
して必要なだけの間隔を空けるようにする。好ましくは
粘着周縁部の幅は5〜10mmが良いため、貼付剤23
の間隔は10〜20+no+空けるようにする。具体的
な方法としては、第2剥離ライナー26の駆動部をパル
スモータ−と制御装置とを組合せて、貼付剤23間の切
断線の所で、第2剥離ライナー26のスピードを一時的
に上げれはよい。また、第1ライナー25の駆動部にス
トップモーターを付けて同様に切断線の所でスピードを
調整することも可能である。The patch 23 peeled off from the release liner 25a is i3
Attach it to the second release liner 26 as shown in Figure c. At this time, a space is provided between adjacent adhesive patches 23 as much as necessary for the adhesive periphery, even if it does not fit between the adhesive patches 23. Preferably, the width of the adhesive periphery is 5 to 10 mm, so the adhesive patch 23
The interval should be 10 to 20+no+. A specific method is to temporarily increase the speed of the second release liner 26 at the cutting line between the patches 23 by combining a pulse motor and a control device to drive the second release liner 26. Yes. It is also possible to attach a stop motor to the drive section of the first liner 25 and adjust the speed at the cutting line in the same way.
次に第3d図に示す通り、抜き型状の薬剤22と支持体
21との貼付剤23とを表面に載せた第2剥飽ライナー
25全表面に剥劇紙27を除去した帯状の粘着シート2
4を貼り合せた後、上方から角丸矩形状の別の抜き型を
有するロール式打ち抜91機39によって抜き型形状の
粘着シー1−24と、その外周の余分な部分の粘着シー
ト31を分動てきるように切断線を入れる。更に、その
余分な部分31を第2剥離ライナー26上から除去する
。この時、粘着シー1−24の形状は貼付剤23の外形
外周に沿って均等な周縁の幅であっても良く、また少な
くとも貼付剤23を広く覆う太きさであればどのような
形状のものても良い。Next, as shown in FIG. 3d, a strip-shaped adhesive sheet with the peeling paper 27 removed from the entire surface of the second peeling liner 25 on which the cutout-shaped drug 22 and the adhesive patch 23 of the support 21 are placed. 2
After bonding 4, the die-shaped adhesive sheet 1-24 and the excess adhesive sheet 31 on its outer periphery are cut out using a roll-type punching machine 39 having another rounded rectangular cutting die from above. Insert a cutting line so that it can move apart. Further, the excess portion 31 is removed from the second release liner 26. At this time, the shape of the adhesive sheet 1-24 may have a uniform peripheral width along the outer circumference of the patch 23, and it may have any shape as long as it has a thickness that at least covers the patch 23 widely. It's good too.
第3e図に示す通り、ロール式裁断機28て貼付剤23
間を小分は裁断して製品35を得た。As shown in Figure 3e, the patch 23 is cut using a roll cutting machine 28.
Product 35 was obtained by cutting the pieces into small pieces.
以上のように第1剥離ライナー25表面上から薬剤22
と支持体21を所定形状に打ち抜き、打ち抜かれた薬剤
22と支持体21前表面に粘着シート24を貼り合せ、
更にそれを所定形状に打ち抜くため、貼付IQ23及び
粘着シート24はそれぞれ剥剛ライナー25.26を覆
うように調製すればよいので、位置決めがし易く、連続
製造か容易となる。また、剥離ライナーを第1、第2と
2段階で使用するようにしたため、薬剤及び支持体部分
のロスが少ない。As described above, the drug 22 is removed from the surface of the first release liner 25.
The support 21 is punched out into a predetermined shape, and an adhesive sheet 24 is pasted on the punched drug 22 and the front surface of the support 21.
Furthermore, in order to punch it into a predetermined shape, the pasting IQ 23 and the adhesive sheet 24 can be prepared so as to cover the rigidifying liner 25, 26, respectively, so that positioning is easy and continuous production is easy. Furthermore, since the release liner is used in the first and second stages, there is less loss of the drug and support portion.
尚、前記第3a、b図において、その終端は次の工程に
連続して続いてもよいし、−旦ドラム等に巻き取っても
よい。In addition, in the above-mentioned figures 3a and 3b, the terminal end may continue to the next step or may be wound up on a drum or the like.
また、前記打ち抜き機29.39や裁断機28は実施例
のものに限定されるものではなく、例えば平版打ち抜き
機等の打ち抜き機を使用してもよく、また裁断機も平刃
式裁断機を使用してもよい。Furthermore, the punching machines 29 and 39 and the cutting machine 28 are not limited to those in the embodiments, and for example, a punching machine such as a lithographic punching machine may be used, and a flat blade type cutting machine may be used as the cutting machine. May be used.
以上のように、本製造方法では、打ち抜き過程で生じる
客扱ぎ型の周りの余分な部分は破棄せざるをえないため
、コストアップとなるが、従来の連続製造に対して、製
造ミスか極端に少ないため、充分に採算か取れる製造方
法である。As described above, in this manufacturing method, the extra parts around the customer-handled mold that occur during the punching process have to be discarded, which increases costs, but compared to conventional continuous manufacturing, manufacturing errors are more likely to occur. Since the amount is extremely small, this manufacturing method is quite profitable.
[発明の効果コ
本発明は以上説明したとおり、薬剤を支持体面上に展延
塗布し、該薬剤面側に第1の剥離ライナーを貼り合せる
工程と;前記第1の剥離ライナーを残して前記支持体と
薬剤との積層体を隣接抜き形状に切断する工程と:前記
隣接した積層体を前記第1の剥離ライナーから剥離し、
前記隣接した積層体間に所定間隔を設けて第2の剥離ラ
イナーに貼り替える工程と;前記積層体を覆うように前
記第2の剥離ライナー表面に粘着シートを貼り合せる工
程、前記積層体を覆う粘着シートを所定の別の抜き形状
に打ち抜き、該抜き形状以外の余分な粘着シートを前記
第2の剥離ライナー上から除去する工程、前記第2の剥
離ライナーを小分は裁断する工程:とを有するものであ
るため、粘着シートの形状を任憇の形状にすることがで
き、貼付部位にフィツトさせることができる。また、剥
離ライナーを第1、第2と2段階で使用するようにした
ため、素材のロスが少ない。[Effects of the Invention] As explained above, the present invention includes the steps of: spreading and coating a drug on the support surface, and bonding a first release liner to the drug surface side; leaving the first release liner behind; cutting the support and drug laminate into adjacent punched shapes; peeling the adjacent laminate from the first release liner;
a step of replacing the adjoining laminates with a second release liner with a predetermined interval between them; a step of pasting an adhesive sheet on the surface of the second release liner so as to cover the laminate; A step of punching out the adhesive sheet into a predetermined different punched shape, removing the excess adhesive sheet other than the punched shape from the second release liner, and cutting the second release liner into small pieces. Therefore, the shape of the pressure-sensitive adhesive sheet can be made into any desired shape, and it can be fitted to the application site. Furthermore, since the release liner is used in two stages, the first and second stages, there is less loss of material.
また第1、第2の剥離ライナーは、それぞれロール状に
つながった状態で用いるので、位置決めし易く、機械的
な流れで製造てきるため、工程中の素材ロスによる費用
に比較して、不良品の低減等により製造効率か非常に優
れているという効果がある。In addition, since the first and second release liners are used in a connected roll, they are easy to position and manufactured using a mechanical process, which reduces the cost of producing defective products compared to the cost of material loss during the process. This has the effect of greatly improving manufacturing efficiency due to the reduction of
第1図は本発明による粘着シート付き貼付剤の構成を示
す上面図であり、第2図は第1図の断面図、第3 a
% e図は粘着シート付き貼付剤の製造工程の一実施例
を示す工程図である。
代理人 弁理士 佐 藤 正 年
第
図
未
図
未
図FIG. 1 is a top view showing the structure of a patch with an adhesive sheet according to the present invention, FIG. 2 is a sectional view of FIG. 1, and FIG.
% e Figure is a process diagram showing an example of the manufacturing process of a patch with an adhesive sheet. Agent: Patent Attorney Tadashi Sato
Claims (1)
離ライナーを貼り合せる工程と; 前記第1の剥離ライナーを残して前記支持体と薬剤との
積層体を隣接抜き形状に切断する工程と; 前記隣接した積層体を前記第1の剥離ライナーから剥離
し、前記隣接した積層体間に所定間隔を設けて第2の剥
離ライナーに貼り替える工程と; 前記抜き形状の薬剤と支持体との積層体を覆うように前
記第2の剥離ライナー表面に粘着シートを貼り合せる工
程と; 前記積層体を覆う粘着シートを所定の別の抜き形状に打
ち抜き、該抜き形状以外の余分な粘着シートを前記第2
の剥離ライナー上から除去する工程と; 前記第2の剥離ライナーを小分け裁断する工程;とを有
することを特徴とする粘着シート付き貼付剤の製造方法
。[Scope of Claims] A step of spreading and coating a drug on the support surface and laminating a first release liner on the drug surface side; and laminating the support and the drug while leaving the first release liner. cutting the body into adjacent punched shapes; peeling the adjacent laminates from the first release liner and replacing them with a second release liner with a predetermined interval between the adjacent laminates; bonding an adhesive sheet to the surface of the second release liner so as to cover the cut-out shaped laminate of the drug and the support; punching out the adhesive sheet covering the laminate into another predetermined cut-out shape; Remove the excess adhesive sheet other than the cutout shape from the second
A method for producing a patch with an adhesive sheet, comprising: removing the second release liner from above; and cutting the second release liner into small pieces.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15390390A JPH0446117A (en) | 1990-06-14 | 1990-06-14 | Preparation of plaster with adhesive sheet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15390390A JPH0446117A (en) | 1990-06-14 | 1990-06-14 | Preparation of plaster with adhesive sheet |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0446117A true JPH0446117A (en) | 1992-02-17 |
Family
ID=15572627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15390390A Pending JPH0446117A (en) | 1990-06-14 | 1990-06-14 | Preparation of plaster with adhesive sheet |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0446117A (en) |
-
1990
- 1990-06-14 JP JP15390390A patent/JPH0446117A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3585128B2 (en) | Method for producing transdermal patch (TTS) | |
US5965154A (en) | Adhesive matrix type transdermal patch and method of manufacturing same | |
JP4541551B2 (en) | Method for producing an adhesive punched product from an endless band, and a punched product produced by this method | |
US9913759B2 (en) | Wound dressing | |
JPH0226508B2 (en) | ||
HU210845B (en) | Process for production of transdermal therapeutic plaster | |
JP2946345B2 (en) | Method for producing a patch with an adhesive sheet | |
JPH07112480B2 (en) | Method for producing wound dressing | |
JPS6277314A (en) | Medicinal pharmaceutical | |
JPH0446117A (en) | Preparation of plaster with adhesive sheet | |
JP6835345B2 (en) | Plaster preparation and its manufacturing method | |
JP4716355B2 (en) | Adhesive patch with adhesive tape and method for producing the same | |
JP2594155B2 (en) | Method for producing haptics with adhesive tape | |
JPH09110679A (en) | Cataplasm | |
JP4344429B2 (en) | New type cataplasm and its manufacturing method | |
JPH0748249A (en) | Ointment plaster | |
KR100463958B1 (en) | A manufacturing method of poultice and poultice therefor | |
JP3460092B2 (en) | Method for producing ointment-based patch | |
JP2004188005A (en) | Plaster, and device and method for producing the same | |
JPH10316557A (en) | Plaster with releasing liner and production of the same | |
JP2001213766A (en) | Poulticle with slit, and its preparation | |
JPH019585Y2 (en) | ||
JP2019108299A (en) | Plaster formulation and method for producing the same | |
JP2020152652A (en) | Patch and manufacturing method thereof | |
JPH10324613A (en) | Sheet-like plaster |